Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-09-19T00:15:57.670Z.
Calculation as of: 2026-09-19T00:15:57.670Z.
Quote observation: 2026-09-18T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9edfc78ac10ef3c00dfd6e8891c60c5ddca660cc4cfb74c64a12c551c30ed6c4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$45.05M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
EV/EBITDA Ratio
13.84x
TTM Avg
31.72x
3Y Avg
207.06x
5Y Avg
207.06x
Market Cap
$1.91B
EV/EBITDA Ratio
4.67x
TTM Avg
7.24x
3Y Avg
37.71x
5Y Avg
27.96x
Market Cap
$2.99B
EV/EBITDA Ratio
28.65x
TTM Avg
36.95x
3Y Avg
87.17x
5Y Avg
87.17x
Market Cap
$5.10B
EV/EBITDA Ratio
16.22x
TTM Avg
16.11x
3Y Avg
20.05x
5Y Avg
21.93x
Market Cap
$5.59B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $463.35M | 23.54x | 15.62x | 15.05x | 16.65x |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 13.84x | 31.72x | 207.06x | 207.06x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 4.67x | 7.24x | 37.71x | 27.96x |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 28.65x | 36.95x | 87.17x | 87.17x |
| Doximity, Inc. (DOCS)vs › | $4.88B | 21.83x | 28.46x | 37.30x | 54.31x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 16.22x | 16.11x | 20.05x | 21.93x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | N/A | 64.66x | 316.14x | 316.14x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
